Literature DB >> 19322521

Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil.

Renato D Lopes1, Richard C Becker, David Garcia, Elaine M Hylek, Christopher B Granger, Dayse M Lourenço, Helena B Nader, Francisco H A Maffei, Fernando H Y Cesena, José C Nicolau, Ari Timmerman, Ana T Rocha, Edison F de Paiva, Helio P Guimaraes, Antonio C Carvalho, Elbio A D'Amico, Carlos A Moreira-Filho, José M Aldrighi, Antonio C Lopes.   

Abstract

The importance of thrombosis and anticoagulation in clinical practice is rooted firmly in several fundamental constructs that can be applied both broadly and globally. Awareness and the appropriate use of anticoagulant therapy remain the keys to prevention and treatment. However, to assure maximal efficacy and safety, the clinician must, according to the available evidence, choose the right drug, at the right dose, for the right patient, under the right indication, and for the right duration of time. The first International Symposium of Thrombosis and Anticoagulation in Internal Medicine was a scientific program developed by clinicians for clinicians. The primary objective of the meeting was to educate, motivate and inspire internists, cardiologists and hematologists by convening national and international visionaries, thought-leaders and dedicated clinician-scientists in Sao Paulo, Brazil. This article is a focused summary of the symposium proceedings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322521     DOI: 10.1007/s11239-009-0324-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

1.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.

Authors:  Elaine M Hylek; Richard C Becker
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

Review 4.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

5.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Authors:  Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno J Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

6.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 7.  The molecular mechanisms of the thrombotic complications of atherosclerosis.

Authors:  P Libby
Journal:  J Intern Med       Date:  2008-05       Impact factor: 8.989

8.  Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.

Authors:  U Alheid; J C Frölich; U Förstermann
Journal:  Thromb Res       Date:  1987-09-01       Impact factor: 3.944

Review 9.  Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.

Authors:  Brian F Gage; Lawrence J Lesko
Journal:  J Thromb Thrombolysis       Date:  2007-10-01       Impact factor: 2.300

10.  The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

Authors:  David G Sherman; Gregory W Albers; Christopher Bladin; Cesare Fieschi; Alberto A Gabbai; Carlos S Kase; William O'Riordan; Graham F Pineo
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

View more
  2 in total

1.  Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, Brazil.

Authors:  Renato D Lopes; David Garcia; Richard C Becker; Christopher B Granger; L Kristin Newby; John H Alexander; E Marc Jolicoeur; Allison Handler; Karen S Pieper; Antonio C Carvalho; Helio P Guimaraes; Dalton A F Chamone; Antonio C Baruzzi; Fabio S Machado; Ari Timerman; Antonio C Lopes
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

2.  Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.

Authors:  Renato D Lopes; Richard C Becker; John H Alexander; Paul W Armstrong; Robert M Califf; Mark Y Chan; Mark Crowther; Christopher B Granger; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Kenneth W Mahaffey; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; Antonio C Carvalho; Roberto R Giraldez; Helio P Guimaraes; Helena B Nader; Renato A K Kalil; Joyce M A Bizzachi; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.